The present study showed that LIBS was non-inferior to conventional food (CSB+) in treating MAM, and both supplements were relatively successful for treating MAM in children aged 6 to 59 months. The finding from this study provides an experimental indication that LIBS can be used as an alternative to CSB+ in the management of MAM in Ethiopia. Thus, the potential for scaling up the use of LIBS should be promoted. Further studies should also examine concerns such as the product’s shelf life, and its sustainability, and cost-effectiveness. Community perceptions of the LIBS as a treatment for MAM should also be tested. The evidence drawn from this study will be shared with the public and with policymakers as LIBS has the potential to increase recovery from MAM and decrease the burden of malnutrition.
Nane D, Hatløy A, Lindtjørn B. (2021). A local-ingredients-based supplement is an alternative to corn-soy blends plus for treating moderate acute malnutrition among children aged 6 to 59 months: A randomized controlled non-inferiority trial in Wolaita, Southern Ethiopia. PLoS ONE 16(10): e0258715.
